Wanfu Biotech (300482.SZ): US subsidiary respiratory triad home self-test OTC products obtained US FDA EUA authorization
Gelonghui May 5 丨 Wanfu Biotech (300482.SZ) issued an announcement that Wanfu Biotech's US wholly-owned subsidiary Wondfo USA Co. , Ltd. (hereinafter referred to as the “US subsidiary”) recently received a notice from U.S. Food & Drug Administration (US Food and Drug Administration, hereinafter referred to as “FDA”) that Wanfu Biotech's US subsidiary's trifecta household test kit for the novel coronavirus, influenza A virus, and influenza B virus (OTC version) WellLife COVID-1
These Analysts Just Made An Incredible Downgrade To Their Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SZSE:002603) EPS Forecasts
The analysts covering Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SZSE:002603) delivered a dose of negativity to shareholders today, by making a substantial revision to their statutory forecasts for
Why Guilin Layn Natural Ingredients' (SZSE:002166) Shaky Earnings Are Just The Beginning Of Its Problems
Guilin Layn Natural Ingredients Corp.'s (SZSE:002166) stock showed strength, with investors undeterred by its weak earnings report. Sometimes, shareholders are willing to ignore soft numbers with the
Impressive Earnings May Not Tell The Whole Story For Shenzhen Kangtai Biological Products (SZSE:300601)
Unsurprisingly, Shenzhen Kangtai Biological Products Co., Ltd.'s (SZSE:300601) stock price was strong on the back of its healthy earnings report. However, we think that shareholders may be missing so
Why Shijiazhuang Yiling Pharmaceutical's (SZSE:002603) Shaky Earnings Are Just The Beginning Of Its Problems
A lackluster earnings announcement from Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SZSE:002603) last week didn't sink the stock price. Our analysis suggests that along with soft profit numbers, in
The Price Is Right For Guilin Layn Natural Ingredients Corp. (SZSE:002166)
Guilin Layn Natural Ingredients Corp.'s (SZSE:002166) price-to-earnings (or "P/E") ratio of 65.1x might make it look like a strong sell right now compared to the market in China, where around half of